We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Antiretroviral Adherence Evaluation in HIV Pregnant and Postpartum Women

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01621347
First Posted: June 18, 2012
Last Update Posted: December 22, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Centre Hospitalier Universitaire Vaudois
Swiss HIV Cohort Study
Information provided by (Responsible Party):
Marie Schneider, Policlinique Médicale Universitaire
May 31, 2012
June 18, 2012
December 22, 2015
March 2012
August 2012   (Final data collection date for primary outcome measure)
Change in patient adherence during pregnancy and postpartum [ Time Frame: before delivery (1 to 9 month) and postpartum (6 month) ]
By electronic drug monitoring, pill count and subject interviews' marks
Same as current
Complete list of historical versions of study NCT01621347 on ClinicalTrials.gov Archive Site
Adherence barriers and facilitators [ Time Frame: pregnancy and postpartum (6 months) ]
Data recorded in subject's interview marks
Same as current
Not Provided
Not Provided
 
Antiretroviral Adherence Evaluation in HIV Pregnant and Postpartum Women
Retrospective Study: Evaluation of Antiretroviral Adherence During Pregnancy and Postpartum Using Electronic Monitoring Data
The purpose of this study is to compare adherence to antiretroviral therapy during pregnancy and postpartum, and to record adherence barriers and facilitators.
Data of all consecutive pregnant women included in the adherence enhancing program of the Pharmacy, Department of ambulatory care & community medicine, are collected. In this program, adherence is measured and enhanced by electronic monitoring, pill count, motivational interviewing and interdisciplinary collaboration. Electronic monitoring data are collected during pregnancy and postpartum, and compared. Barriers and facilitators are collected using interview's marks.
Observational
Observational Model: Case-Only
Time Perspective: Retrospective
Not Provided
Not Provided
Non-Probability Sample
Pregnant and Postpartum Women enrolledin the HIV adherence program at the pharmacy of Department of Ambulatory Care and Community Medicine in Lausanne
  • HIV Infection
  • Pregnancy
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
26
September 2012
August 2012   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Pregnant Women
  • HIV-positive
  • Antiretroviral medication delivered in electronical monitors

Exclusion Criteria:

  • Monitored period during pregnancy < 1 month
Sexes Eligible for Study: Female
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Switzerland
 
 
NCT01621347
48/12
No
Not Provided
Not Provided
Marie Schneider, Policlinique Médicale Universitaire
Policlinique Médicale Universitaire
  • Centre Hospitalier Universitaire Vaudois
  • Swiss HIV Cohort Study
Study Chair: Marie-Paule Schneider, PhD Policlinique Médicale Universitaire
Principal Investigator: Aurélie Gertsch, PhD-Student Policlinique Médicale Universitaire
Study Chair: Olivier Bugnon, Professor Policlinique Médicale Universitaire
Principal Investigator: Odile Michel, Student Policlinique Médicale Universitaire
Study Chair: Matthias Cavassini, M.D Centre Hosppitalier Universitaire Vaudois
Policlinique Médicale Universitaire
December 2015